NEW YORK (GenomeWeb News) – In a sort of test case for personalized medicine, a team of clinicians and researchers used whole-genome sequencing to uncover variants possibly linked to a patient's obsessive-compulsive disorder. But, as Cold Spring Harbor Laboratory's Gholson Lyon and his colleagues reported in the journal PeerJ yesterday, knowing those variants did not change that patient's treatment for OCD.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.